Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ)
CNY 18.76
(-0.11%)
CNY 18.76
(-0.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -239.39 Million CNY | 44.54% |
| 2022 | -431.68 Million CNY | -46.21% |
| 2021 | -295.25 Million CNY | 7.27% |
| 2020 | -318.4 Million CNY | -512.9% |
| 2019 | -51.94 Million CNY | -23.32% |
| 2018 | -42.12 Million CNY | 11.24% |
| 2017 | -47.45 Million CNY | 27.92% |
| 2016 | -65.84 Million CNY | -213.39% |
| 2015 | -21.01 Million CNY | -164.17% |
| 2014 | -7.95 Million CNY | 46.64% |
| 2013 | -14.9 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 5.99 Million CNY | 104.54% |
| 2024 Q1 | -220.48 Million CNY | 7.9% |
| 2024 Q2 | -132.16 Million CNY | 40.06% |
| 2023 Q4 | -239.39 Million CNY | 36.94% |
| 2023 FY | -239.39 Million CNY | 44.54% |
| 2023 Q1 | -400.4 Million CNY | 7.25% |
| 2023 Q2 | -386.12 Million CNY | 3.57% |
| 2023 Q3 | -379.62 Million CNY | 1.68% |
| 2022 Q4 | -431.68 Million CNY | -32.15% |
| 2022 FY | -431.68 Million CNY | -46.21% |
| 2022 Q2 | -266.07 Million CNY | 28.67% |
| 2022 Q3 | -326.67 Million CNY | -22.77% |
| 2022 Q1 | -373.02 Million CNY | -26.34% |
| 2021 Q2 | -291.94 Million CNY | 4.31% |
| 2021 Q4 | -295.25 Million CNY | -0.33% |
| 2021 FY | -295.25 Million CNY | 7.27% |
| 2021 Q1 | -305.09 Million CNY | 5.29% |
| 2021 Q3 | -294.28 Million CNY | -0.8% |
| 2020 FY | -318.4 Million CNY | -512.9% |
| 2020 Q2 | -258.33 Million CNY | 3.86% |
| 2020 Q4 | -322.15 Million CNY | -16.05% |
| 2020 Q3 | -277.59 Million CNY | -7.46% |
| 2020 Q1 | -268.71 Million CNY | -417.26% |
| 2019 Q1 | 44.4 Million CNY | 200.0% |
| 2019 Q3 | -40.5 Million CNY | -55.47% |
| 2019 FY | -51.94 Million CNY | -23.32% |
| 2019 Q4 | -51.94 Million CNY | -28.26% |
| 2019 Q2 | -26.05 Million CNY | -158.67% |
| 2018 Q4 | -44.4 Million CNY | 0.0% |
| 2018 FY | -42.12 Million CNY | 11.24% |
| 2017 Q4 | -47.45 Million CNY | 3.45% |
| 2017 Q2 | -46.41 Million CNY | 0.0% |
| 2017 FY | -47.45 Million CNY | 27.92% |
| 2017 Q3 | -49.15 Million CNY | -5.89% |
| 2017 Q1 | -46.41 Million CNY | 29.65% |
| 2016 Q1 | -55.25 Million CNY | -162.99% |
| 2016 Q4 | -65.98 Million CNY | 0.0% |
| 2016 Q3 | -65.98 Million CNY | -19.41% |
| 2016 Q2 | -55.25 Million CNY | 0.0% |
| 2016 FY | -65.84 Million CNY | -213.39% |
| 2015 Q1 | -4.39 Million CNY | 44.71% |
| 2015 Q2 | -24.56 Million CNY | -458.69% |
| 2015 Q3 | -21.01 Million CNY | 14.48% |
| 2015 FY | -21.01 Million CNY | -164.17% |
| 2015 Q4 | -21.01 Million CNY | 0.0% |
| 2014 Q3 | -7.95 Million CNY | 0.0% |
| 2014 FY | -7.95 Million CNY | 46.64% |
| 2014 Q1 | 14.9 Million CNY | 0.0% |
| 2014 Q4 | -7.95 Million CNY | 0.0% |
| 2013 FY | -14.9 Million CNY | 0.0% |